CALA Crosses Above Average Analyst Target
May 22, 2017 at 10:47 AM EDT
In recent trading, shares of Calithera Biosciences, Inc. (CALA) have crossed above the average analyst 12-month target price of $15.17, changing hands for $16.10/share..
